Promosome v BioNTech (CFI, 9 April 2025)
| Date | 9 April 2025 |
|---|---|
| Court | CFI |
| Division | Munich (DE) Local Division |
| Type of action | Generic application |
| Registry reference | App_11272/2025 · ORD_11613/2025 |
| Parties | Pfizer AB , Pfizer SAS, Pfizer, Inc. , Pfizer Manufacturing Belgium NV |
Summary pending review. Official UPC registry metadata imported on 24 September 2026.
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
English summary awaiting review. Read the French case note.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
No case number recorded in this record.
Parties
- claimantPfizer Manufacturing Belgium NV9 decisions in the corpusFollow this party
- claimantPfizer, Inc.7 decisions in the corpusFollow this party
- claimantPfizer SAS7 decisions in the corpusFollow this party
- claimantPfizer AB7 decisions in the corpusFollow this party
Exact name as it appears in the record, group affiliation only where sourced and dated.
Decisions in the same proceedings and documented appeals
No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.
What the record states
- Nature of the act
- Generic application
- Outcome (Dhenne Avocats summary)
- Promosome doit consigner une garantie de 1 500 000 EUR dans les trois semaines, répartie entre les deux groupes de défenderesses. La demande de décision par défaut est prématurée.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 2 401 365mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- BioNTech Manufacturing Marburg (CFI, 9 April 2025) cites this decision
Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 2 401 365Reengineering mrna primary structure for enhanced protein production recorded proprietor: Scripps Research Institute | Mentioned in the analysis (role not qualified) Also mentioned in 6 other decision(s): Promosome v BioNTech (CFI, UPC_CFI_846/2024, 7 July 2026) · Promosome v BioNTech (CFI, 15 July 2025) · Promosome v BioNTech (CFI, 17 April 2025) · Promosome v BioNTech (CFI, 3 April 2025) · Promosome v BioNTech (CFI, 10 March 2025) · Promosome v BioNTech (CoA, 12 October 2026) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.